We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3481:TWSEInnolux Corp. Analysis

Data as of 2026-07-23 - not real-time

NT$51.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its short‑term moving averages, with the 20‑day SMA comfortably above the market price and the 50‑day SMA also higher. Momentum indicators are neutral to bearish – the RSI sits in the lower‑mid range and the MACD histogram is negative, while the broader trend is still classified as bullish. Volume has been tapering, and the 30‑day volatility is markedly high, suggesting price swings may continue. Market sentiment is at an extreme greed level, which could be inflating short‑term buying pressure.
Fundamental backdrop: Revenue is growing robustly year over year, yet margins remain thin and profitability is marginal. The price‑to‑earnings multiple is astronomically high relative to peers, indicating the market is pricing in future earnings upside that have yet to materialize. Cash balances exceed debt, but the debt‑to‑equity ratio is elevated, and return on equity is minimal. The discounted cash‑flow model points to a fair value above the current price, while the dividend yield is modest with a payout ratio that may be difficult to sustain given the low earnings base.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price below short‑term SMAs
  • bearish MACD signal
  • declining volume and high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • strong revenue growth trajectory
  • DCF fair value above market price
  • reasonable dividend yield relative to cash position

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • persistent low profitability and thin margins
  • high debt level offset by ample cash
  • uncertain sustainability of dividend and earnings expansion

Key Metrics & Analysis

Financial Health

Revenue Growth19.20%
Profit Margin0.39%
P/E Ratio1730.0
ROE0.59%
ROA-0.24%
Debt/Equity24.01
P/B Ratio1.8
Op. Cash FlowNT$29.2B
Free Cash FlowNT$17.2B
Industry P/E33.7

Technical Analysis

TrendBullish
RSI40.2
SupportNT$49.10
ResistanceNT$72.50
MA 20NT$61.15
MA 50NT$55.07
MA 200NT$28.92
MACDBearish
VolumeDecreasing
Fear & Greed Index91.71

Valuation

Fair ValueNT$64.28
Target PriceNT$47.13
Upside/Downside-9.18%
GradeOvervalued
TypeGrowth
Dividend Yield1.90%

Risk Assessment

Beta0.49
Volatility76.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.